Latest On Natural Beauty Bio-Technology Limited (NBBTF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-06-03 06:10 EST | Dividend | A dividend of $0 has been announced on Mar 22, 2022. It will be paid Jul 28, 2022 with an ex-dividend date of Jun 3, 2022. | Neutral |  |
| 2021-06-02 06:27 EST | Dividend | A dividend of $0 has been announced on Mar 24, 2021. It will be paid Jul 28, 2021 with an ex-dividend date of Jun 2, 2021. | Neutral | |
| 2020-12-16 15:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-05 10:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-04 06:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-27 00:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-08 21:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 09:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 16:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 00:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 16:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 16:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 21:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 12:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 07:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 23:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 20:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 04:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-25 07:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 16:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 08:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 09:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-07 19:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-05 15:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-03 19:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 08:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 04:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-14 03:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-07 11:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-07 03:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 09:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 23:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 20:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-30 07:30 EST | Financials | Company financials have been released. | Neutral | |
About Natural Beauty Bio-Technology Limited (NBBTF):
Natural Beauty Bio-Technology Limited, an investment holding company, manufactures and sells skin care, beauty, aroma-therapeutic, and health supplements and make-up products under the Natural Beauty brand in the People's Republic of China, Taiwan, and internationally. It also offers skin treatment, beauty and spa, medical cosmetology, and skin care consulting and beauty training services. The company's spas provide various services, including hydrotherapy, facial treatment, body care, and skin care analysis. In addition, it engages in the wholesale of skin care and beauty products. The company was founded in 1972 and is based in Wan Chai, Hong Kong.
General
- Name Natural Beauty Bio-Technology Limited
- Symbol NBBTF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- Full Time Employees 655
- Fiscal Year EndDecember
- Web URLhttp://www.nblife.com
View More
Valuation
- Trailing PE 159.62
- Price/Sales (Trailing 12 Mt.) 3.58
- Price/Book (Most Recent Quarter) 2.52
- Enterprise Value Revenue 0.45
- Enterprise Value EBITDA 94.3
View More
Financials
- Most Recent Quarter 2020-06-30
- Profit Margin 0%
- Earnings Per Share $0.01
- Revenue Per Share $0
- Gross Profit 265.57 million
- Quarterly Earnings Growth -23.6%
View More
Highlights
- Market Capitalization 190.81 million
- Book Value Per Share $0.04
View More
Share Statistics
- Shares Outstanding 2 billion
- Shares Float 500.53 million
- % Held by Insiders 2224%
View More
Technicals
- Beta -0.14
- 52 Week High $0.15
- 52 Week Low $0.05
- 50 Day Moving Average 0.42
- 200 Day Moving Average 0.16
View More
Dividends
- Dividend Date N/A
- ExDividend Date 2018-10-15
- Dividend Yield 0%
View More
Natural Beauty Bio-Technology Limited (NBBTF) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Natural Beauty Bio-Technology Limited (NBBTF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-03-31 | 2020-06-30 | $N/A | $-0.00 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $129.77 million | $-0.00 | $0.00 | |
| 2019-09-30 | 2019-12-31 | $129.77 million | $0.00 | $0.00 | |
| 2019-06-30 | 2019-09-30 | $102.44 million | $0.00 | $0.00 | |
| 2019-03-31 | 2019-06-30 | $102.44 million | $0.00 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $87.89 million | $0.00 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $87.89 million | $-0.00 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $96.87 million | $-0.00 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $96.87 million | $0.00 | $0.00 | |
| 2017-12-31 | 2018-03-31 | $32.6 million | $0.00 | $0.00 | |
| 2017-09-30 | 2017-12-31 | $34.23 million | $0.00 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $91.81 million | $0.00 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $91.81 million | $0.00 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $117.49 million | $0.00 | $0.00 | |
| 2016-09-30 | 2016-12-31 | $117.49 million | $0.00 | $0.00 | |
| 2016-06-30 | 2016-09-30 | $0.00 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | $0.00 | $0.00 | ||
| 2015-12-31 | 2016-03-31 | $0.00 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | $0.00 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | $0.00 | $0.00 | ||
| 2015-03-31 | 2015-06-30 | $0.00 | $0.00 | ||
| 2014-12-31 | 2015-03-31 | $0.00 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | $0.00 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | $0.00 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.00 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.00 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.00 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.00 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.00 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.00 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.00 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.00 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.00 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.00 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.00 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.00 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.00 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.00 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.00 | $0.00 |
Natural Beauty Bio-Technology Limited (NBBTF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | 16.65 million | 16.65 million | 7.6 million |
| Selling General Administrative | N/A | N/A | 57.94 million | 57.94 million | 58.25 million |
| Gross Profit | N/A | N/A | 77.06 million | 77.06 million | 65.58 million |
| Ebit | N/A | N/A | 19.08 million | 19.08 million | 6.29 million |
| Operating Income | N/A | N/A | 19.08 million | 19.08 million | 6.29 million |
| Income Tax Expense | -2.38 million | -2.38 million | 6.63 million | 6.63 million | 2.72 million |
| Total Revenue | N/A | N/A | 129.77 million | 129.77 million | 102.44 million |
| Cost of Revenue | N/A | N/A | 52.71 million | 52.71 million | 36.86 million |
| Total Other Income Expense Net | N/A | N/A | -2.42 million | -2.42 million | 272000 |
| Net Income From Continuing Operations | N/A | N/A | 10.02 million | 10.02 million | 4.88 million |
| Net Income Applicable to Common Shares | -3.22 million | -3.22 million | 10.02 million | 10.02 million | 4.88 million |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | -19.06 million | -19.06 million | N/A | N/A | -6.5 million |
| Net Borrowings | 9.78 million | 9.78 million | N/A | N/A | -3.14 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | -3.14 million |
| Change to Operating Activities | N/A | N/A | N/A | N/A | N/A |
| Change in Cash | N/A | N/A | N/A | N/A | -10.7 million |
| Total Cash from Operating Activities | 4.51 million | 4.51 million | N/A | N/A | -28000 |
| Depreciation | N/A | N/A | N/A | N/A | 9.28 million |
| Other Cash Flow from Investing Activities | 381500 | 381500 | N/A | N/A | 2.03 million |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | -400000 | -400000 | N/A | N/A | N/A |
| Change to Net Income | -3.62 million | -3.62 million | N/A | N/A | -14.19 million |
| Capital Expenditures | N/A | N/A | N/A | N/A | 8.53 million |
Balance Sheet:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 200.21 million | 200.21 million | 154.31 million |
| Total Stockholder Equity | N/A | N/A | 599.54 million | 599.54 million | 559.01 million |
| Other Current Liabilities | 26.09 million | 26.09 million | 60.78 million | 60.78 million | 62.39 million |
| Total Assets | N/A | N/A | 799.75 million | 799.75 million | 713.32 million |
| Common Stock | 200.21 million | 200.21 million | 200.21 million | 200.21 million | 200.21 million |
| Other Current Assets | 622000 | 622000 | 664000 | 664000 | 694000 |
| Retained Earnings | N/A | N/A | N/A | N/A | 198.88 million |
| Other Liabilities | 661000 | 661000 | 9.71 million | 9.71 million | 1.28 million |
| Other Assets | 21.22 million | 21.22 million | 61.03 million | 61.03 million | 16.5 million |
| Cash | N/A | N/A | 145.7 million | 145.7 million | 159.62 million |
| Total Current Liabilities | 162.53 million | 162.53 million | 142.14 million | 142.14 million | 136.57 million |
| Other Stockholder Equity | 353.52 million | 353.52 million | 399.33 million | 399.33 million | 106.26 million |
| Property, Plant & Equipment | 356.75 million | 356.75 million | 332.31 million | 332.31 million | 303.57 million |
| Total Current Assets | 338.06 million | 338.06 million | 365.99 million | 365.99 million | 345.66 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 512.38 million | 512.38 million | 559.12 million | 559.12 million | 511.42 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | 23.82 million | 23.82 million | N/A |
| Inventory | 101.86 million | 101.86 million | 79.3 million | 79.3 million | 82.58 million |
| Accounts Payable | 98.76 million | 98.76 million | 27.65 million | 27.65 million | 33.65 million |
Natural Beauty Bio-Technology Limited (NBBTF) Chart:
Natural Beauty Bio-Technology Limited (NBBTF) News:
Below you will find a list of latest news for Natural Beauty Bio-Technology Limited (NBBTF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Natural Beauty Bio-Technology Limited (NBBTF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Natural Beauty Bio-Technology Limited (NBBTF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|